Kutlar, Abdullah
University of North Carolina at Chapel Hill · Medical University of South Carolina · Universidade de São Paulo · Universidade Estadual de Campinas (UNICAMP) · East Carolina University · Augusta University · Hospital de Clínicas de Porto Alegre
7 papers on CoChatORCID 0000-0002-5482-8087
Most cited papers
- Verified
Prevention of a First Stroke by Transfusions in Children with Sickle Cell Anemia and Abnormal Results on Transcranial Doppler Ultrasonography
Adams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine
Hemoglobinopathies and Related DisordersBlood transfusion and management
Cited by 1,866
- Verified
Crizanlizumab for the prevention of pain crises in sickle cell disease.
Ataga, K. I., Kutlar, A., Kanter, J., Liles, D., Cancado, R., Friedrisch, J., Guthrie, T. H., Knight-Madden, J., Alvarez, O. A., Gordeuk, V. R., et al. (2017) · New England Journal of Medicine
Hemoglobinopathies and Related DisordersBlood groups and transfusion
Cited by 914
- Verified
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)
Wang, W. C., Ware, R. E., Miller, S. T., Iyer, R. V., Casella, J. F., Minniti, C. P., Rana, S., Thornburg, C. D., Rogers, Z. R., Kalpatthi, R. V., et al. (2011) · The Lancet
Hemoglobinopathies and Related DisordersNeonatal Health and Biochemistry
Cited by 803
- Verified
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial
Ware, R. E., Davis, B. R., Schultz, W. H., Brown, R. C., Aygun, B., Sarnaik, S., Odame, I., Fuh, B., George, A., Owen, W., et al. (2016) · The Lancet
Hemoglobinopathies and Related DisordersNeonatal Health and Biochemistry
Cited by 515
- Verified
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up
Steinberg, M. H., McCarthy, W. F., Castro, O., Ballas, S. K., Armstrong, F. D., Smith, W., Ataga, K., Swerdlow, P., Kutlar, A., DeCastro, L., et al. (2010) · American Journal of Hematology
Hemoglobinopathies and Related DisordersBlood groups and transfusion
Cited by 486
- Verified
Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell disease
Anea, C. B., Lyon, M., Lee, I. A., Gonzales, J. N., Adeyemi, A., Falls, G., Kutlar, A., & Brittain, J. E. (2016) · American Journal of Hematology
Hemoglobinopathies and Related DisordersPlatelet Disorders and Treatments
Cited by 40
- Verified
Sickle Cell Telemedicine and Standard Clinical Encounters: A Comparison of Patient Satisfaction
Woods, K. F., Kutlar, A., Johnson, J. A., Waller, J. L., Grigsby, R. K., Stachura, M. E., & Rahn, D. W. (1999) · Telemedicine Journal
Telemedicine and Telehealth ImplementationPatient Satisfaction in Healthcare
Cited by 30
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free